|
KLHL7 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.660030E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.759800E-01 |
| Normal-vs-Stage2 |
6.851200E-01 |
| Normal-vs-Stage3 |
3.504200E-02 |
| Normal-vs-Stage4 |
5.097800E-03 |
| Stage1-vs-Stage2 |
5.302800E-01 |
| Stage1-vs-Stage3 |
1.509880E-02 |
| Stage1-vs-Stage4 |
2.804000E-03 |
| Stage2-vs-Stage3 |
3.223000E-01 |
| Stage2-vs-Stage4 |
1.470790E-01 |
| Stage3-vs-Stage4 |
4.936200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.872800E-01 |
| Normal-vs-AfricanAmerican |
4.983800E-01 |
| Normal-vs-Asian |
6.454400E-01 |
| Caucasian-vs-AfricanAmerican |
9.259200E-01 |
| Caucasian-vs-Asian |
5.714800E-01 |
| AfricanAmerican-vs-Asian |
6.311600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.555990E-01 |
| Normal-vs-Female |
3.832800E-01 |
| Male-vs-Female |
7.299600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.618200E-01 |
| Normal-vs-Age(41-60Yrs) |
3.252000E-01 |
| Normal-vs-Age(61-80Yrs) |
2.216400E-01 |
| Normal-vs-Age(81-100Yrs) |
2.930400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.868400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.107200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.527800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.270600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.930170E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.355000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.855200E-01 |
| Normal-vs-Grade 2 |
6.332200E-01 |
| Normal-vs-Grade 3 |
8.290400E-02 |
| Normal-vs-Grade 4 |
1.362680E-04 |
| Grade 1-vs-Grade 2 |
7.002000E-01 |
| Grade 1-vs-Grade 3 |
2.214200E-01 |
| Grade 1-vs-Grade 4 |
1.384120E-02 |
| Grade 2-vs-Grade 3 |
3.744400E-02 |
| Grade 2-vs-Grade 4 |
5.74959999999347E-05 |
| Grade 3-vs-Grade 4 |
1.633780E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.598800E-01 |
| Normal-vs-ccB subtype |
1.800200E-01 |
| ccA subtype-vs-ccB subtype |
4.968100E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.496200E-01 |
| Normal-vs-N1 |
1.166620E-01 |
| N0-vs-N1 |
2.656400E-01 |
|
|
